The departments of Health and Human Services, Labor, and Treasury (the Tri-Agencies) reopened the independent dispute resolution (IDR) process for new single payment disputes, including claims where services are bundled into one payment amount on Oct. 6, 2023. Accompanying guidance indicates that the IDR process for batched and air ambulance disputes remains suspended while the Tri-Agencies update their guidance and systems to reflect recent court orders that stem from recent rulings in the U.S. District Court for the Eastern District of Texas.
The Food and Drug Administration (FDA) has published a proposed rule on the regulation of laboratory developed tests (LDTs). Comments on the proposed rule are due Dec. 4.
The Substance Abuse and Mental Health Services Administration has awarded $35 million in grants to expand access to behavioral health and HIV treatment and prevention services for racial and ethnic medically underserved people.
Don’t wait until the last minute to ensure your hospital prepares the seismic reports due by the end of the year. Access the recording and slide deck of CHA’s Sept. 26 webinar — and get the information you need to complete your reports on time.
On Oct. 3-4, CHA hosted its 2023 Disaster Planning Conference at the Sacramento Convention Center, which featured a keynote session from Natalie Johnson of management consulting firm ViDL Solutions on “Cultivating Energy in Our Modern World” and a general session from PG&E leadership staff on “Utility Response During Emergency Events.”
On Oct. 4, the Department of Health Care Services (DHCS) notified CHA that due to the passage of House Resolution 5860, which delayed the implementation of the Affordable Care Act Disproportionate Share Hospital (DSH) reduction until after Nov. 17, the department will not reduce the July-September 2023 round of DSH payments.
HQI and CHPSO will host a webinar on the impact of drug shortages on patients and health care operations on Oct. 18 at 11 a.m. (PT).
The California Department of Public Health (CDPH) has issued All Facilities Letter (AFL) 23-29, recommending that all residents of skilled-nursing facilities (SNFs) with symptomatic COVID-19 be evaluated by a prescribing clinician to be considered for COVID-19 therapeutics, any oral COVID-19 therapeutics drug-drug interaction risk, and/or renal and hepatic impairment in advance of a COVID-19 diagnosis.